Tadalafil, commonly known by its brand name Cialis, is widely prescribed for erectile dysfunction. However, some biohacking and wellness circles now explore its potential for cardiovascular health, brain benefits, and athletic performance. While tadalafil is not approved to prevent heart attacks or strokes, nor to extend life, some cardiologists and men’s health experts see its promise in preventive health.
Interest from Experts
Dr. Robert Kloner from the Huntington Medical Research Institute notes the serious discussions around tadalafil’s preventive benefits. Cardiovascular disease is the leading cause of death, and these drugs might offer potential advantages. Despite this, extensive research is still needed to understand these potential benefits fully.
Longevity Buzz
Tadalafil belongs to the same drug class as sildenafil (Viagra), yet its effects last longer. Several important studies have associated these drugs with lower rates of cardiovascular disease, mortality, and dementia. However, these observational studies cannot definitively prove tadalafil causes these benefits. Dr. Kloner notes consistent findings across various studies, sparking online discussions about using tadalafil for more than sexual health.
Real-World Use
Kristi Sawicki, a molecular oncology expert, is among those experimenting with tadalafil for longevity. With a history of heart disease in her family, she pursued tadalafil for its cardiovascular benefits, and also noticed athletic improvements. While traditionally used for erectile dysfunction, tadalafil and sildenafil are approved for treating lung-related high blood pressure and enlarged prostate symptoms, working by relaxing and widening blood vessels throughout the body. Originally developed to treat chest pain, these drugs showed other vascular benefits, prompting interest in their broader uses.
Research Findings
Research in lab and animal studies suggests tadalafil could have anti-inflammatory effects, with human studies showing significant improvements in health outcomes. For example, Kloner’s analysis of over 8,000 men showed a 55% reduction in cardiovascular deaths and a 44% lower overall mortality rate. Large-scale studies have also indicated a lower dementia risk and improved longevity among tadalafil users. Yet, Kloner and other researchers stress the need for prospective, randomized studies to verify these findings, noting limited research on women.
Challenges in Research and Acceptance
Pharmaceutical companies lack incentives for costly studies on widely available generics, slowing scientific validation. While some online clinics promote tadalafil for longevity, experts like Dr. Steve Nissen from the Cleveland Clinic caution against off-label use without randomized trial evidence.
Panel Discussion
Emerging consensus among medical experts suggests potential wider acceptance of tadalafil beyond its primary use. At a recent meeting of the Princeton Consensus Panel, language was proposed endorsing low-dose tadalafil for men with heightened cardiovascular risks.
Dr. Martin Miner, who led the panel, noted some hesitation due to the lack of randomized trials, but endorsements were made based on observational data. Miner highlighted the importance of supporting men at higher cardiovascular risk, emphasizing the need to bridge the longevity gap.